Discover how our dedicated clinical manufacturing sites in the US and EU provide the technical expertise and agility needed to advance your clinical batch supply.

The transition from preclinical to clinical development is a critical step in the development of a drug product.

As your molecule enters first in-human trials, your manufacturing needs evolve rapidly – from clinical material supply to analytical testing, and regulatory readiness.

At Vetter, we offer aligned processes and reliable support tailored to your individual needs during key development phases.  With over 45 years of experience in aseptic filling of complex compounds and sensitive biologics, we are committed to meeting your critical timelines while maintaining high quality standards.